Glomerular hyperfiltration: a marker of early renal damage in pre-diabetes and pre-hypertension.

Glomerular hyperfiltration is a characteristic functional abnormality in insulin-dependent diabetes mellitus and occurs in the large majority of young Type 1 diabetic patients. Hyperfiltration is hypothesized to be a precursor of intraglomerular hypertension leading to albuminuria. Glomerular filtration rate (GFR) then falls progressively in parallel with a further rise in albuminuria which may lead, in the long run, to end-stage renal failure. Experimental and clinical studies have shown that glomerular hyperfiltration can occur also in hypertension. However, whether hyperfiltration occurs also in early stages of hyperglycaemia and high blood pressure, such as in pre-diabetes and pre-hypertension, is not well known. In this issue of the Journal, Okada and Coll studied a large Japanese population showing that in pre-diabetic and pre-hypertensive subjects, the prevalence of hyperfiltration is proportional to the level of glucose and blood pressure, respectively. One main problem with the diagnosis of hyperfiltration is that no generally accepted definition is available due to the strong inverse correlation of GFR with age. To overcome this limitation, Okada et al. calculated the upper normal limit of GFR in a large healthy Japanese sample divided into 10-year age groups, providing ageand sex-specific reference values. For hyperfiltration to develop, the concomitant action of a variety of pathogenetic factors are needed including increased body mass index, hyperinsulinaemia, activation of the sympathetic nervous system, hyperleptinaemia, increased oxidative stress, inflammatory cytokines, etc. Another mechanism accounting for increased GFR in obese persons is increased NaCl intake. In addition, a significant role of increased Na reabsorption in the pathophysiology of glomerular hyperfiltration in obesity and hypertension has been described. Pharmacological agents with action on the renin–angiotensin system are effective in reducing glomerular hypertension which accounts for their efficacy in preventing progression of microalbuminuria in diabetes and hypertension. According to current guidelines, only low GFR and microalbuminuria or proteinuria should be considered as markers of renal dysfunction. Due to the strong association between hyperfiltration and risk of microalbuminuria found in diabetes and hypertension, hyperfiltration should be regarded as a precursor of nephropathy in these clinical conditions. More extensive use of markers of early organ damage may help clinicians to reach a more timely decision about the initiation of treatment and thus delay cardiovascular complications. Hyperglycaemia and high blood pressure in people with hyperfiltration should be treated earlier to prevent the progression of renal dysfunction to chronic kidney disease. Increased GFR, also called hyperfiltration, is a proposed mechanism for renal injury in several clinical conditions. According to the Brenner theory [1], low nephron number at birth explains why some individuals are prone to developing progressive renal damage later in life when other risk factors become operative. At the single-nephron level, hyperfiltration is hypothesized to be a precursor of intraglomerular hypertension leading to albuminuria. Increased glomerular capillary hydraulic pressure may be due to changes in systemic arterial pressure and/or changes in efferent and afferent arteriolar resistances. In the absence of therapeutic interventions, GFR then falls progressively in parallel with a further rise in albuminuria which may lead, in the long run, to end-stage renal failure (Figure 1). Human models of renal injury are in keeping with this pathogenetic view. Glomerular hyperfiltration has been observed in patients with unilateral renal agenesis [2], congenitally reduced nephron number [3] and acquired reduction in renal mass [4]. These individuals are prone to developing proteinuria early in life in association with glomerular sclerosis. It is suggested that this model of renal injury may apply to the early diabetic or hypertensive kidney.

[1]  N. Vaziri,et al.  Intra-Renal Angiotensin II/AT1 Receptor, Oxidative Stress, Inflammation, and Progressive Injury in Renal Mass Reduction , 2007, Journal of Pharmacology and Experimental Therapeutics.

[2]  N. Tomita,et al.  Deterioration of glomerular endothelial surface layer induced by oxidative stress is implicated in altered permeability of macromolecules in Zucker fatty rats , 2010, Diabetologia.

[3]  R. Blantz,et al.  Glomerular Hyperfiltration and the Salt Paradox in Early Type 1 Diabetes Mellitus: A Tubulo-Centric View , 2003 .

[4]  J. Dubernard,et al.  [The kidney]. , 2011, Bulletin de l'Academie nationale de medecine.

[5]  P. Codoñer-Franch,et al.  Oxidant/antioxidant status and hyperfiltration in young patients with type 1 diabetes mellitus , 2009, Pediatric Nephrology.

[6]  A. Dominiczak,et al.  Glomerular hyperfiltration: a new marker of metabolic risk. , 2007, Kidney international.

[7]  H. Parving,et al.  Effects of acetazolamide on kidney function in Type 1 (insulin-dependent) diabetic patients with diabetic nephropathy , 1988, Diabetologia.

[8]  N. Hamajima,et al.  Glomerular hyperfiltration in prediabetes and prehypertension. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  D. Gaudet,et al.  Predictors of Target Organ Damage in Hypertensive Blacks and Whites , 2001, Hypertension.

[10]  J. Satriano Kidney growth, hypertrophy and the unifying mechanism of diabetic complications , 2007, Amino Acids.

[11]  E. Tremoli,et al.  Cytokines present in smokers' serum interact with smoke components to enhance endothelial dysfunction. , 2011, Cardiovascular research.

[12]  M. G. Cogan,et al.  Angiotensin II: a powerful controller of sodium transport in the early proximal tubule. , 1990, Hypertension.

[13]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[14]  B. Brenner,et al.  Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists. , 2000, Kidney international.

[15]  V. Campese,et al.  Abnormal Renal Hemodynamics in Black Salt-Sensitive Patients With Hypertension , 1991, Hypertension.

[16]  F. Kaskel,et al.  The role of obesity and its bioclinical correlates in the progression of chronic kidney disease. , 2006, Advances in chronic kidney disease.

[17]  T. Ichiki Collaboration between smokers and tobacco in endothelial dysfunction. , 2011, Cardiovascular research.

[18]  R. Schmieder,et al.  Glomerular hyperfiltration indicates early target organ damage in essential hypertension. , 1990, JAMA.

[19]  P. Savage,et al.  Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. , 1989, The New England journal of medicine.

[20]  G. Luippold,et al.  Chronic renal denervation prevents glomerular hyperfiltration in diabetic rats. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  T. Weinstein,et al.  The effects of weight loss on renal function in patients with severe obesity. , 2003, Journal of the American Society of Nephrology : JASN.

[22]  H. Rüddel,et al.  Predictors for hypertensive nephropathy: results of a 6‐year follow‐up study in essential hypertension , 1995, Journal of hypertension.

[23]  R. MacIsaac,et al.  Renal hyperfiltration in type 2 diabetes: effect of age-related decline in glomerular filtration rate , 2005, Diabetologia.

[24]  C. Zoccali,et al.  Does high salt intake cause hyperfiltration in patients with essential hypertension? , 1996, Journal of human hypertension.

[25]  A. Luke,et al.  Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[26]  L. Lerman,et al.  Increased glomerular filtration rate in early metabolic syndrome is associated with renal adiposity and microvascular proliferation. , 2011, American journal of physiology. Renal physiology.

[27]  K. K. Sato,et al.  Cigarette smoking and the association with glomerular hyperfiltration and proteinuria in healthy middle-aged men. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[28]  P. Piazolo,et al.  Progressive renal failure in a remnant kidney. , 1986, British medical journal.

[29]  C. Zoccali Overweight, obesity and metabolic alterations in chronic kidney disease. , 2009, Prilozi.

[30]  A. Dominiczak,et al.  2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. , 2007, Journal of hypertension.

[31]  F. Ruschitzka,et al.  Vasopeptidase inhibition restores renovascular endothelial dysfunction in salt-induced hypertension. , 2001, Journal of the American Society of Nephrology : JASN.

[32]  D. Fernandes,et al.  Tobacco Smoke Induces Ventricular Remodeling Associated with an Increase in NADPH Oxidase Activity , 2011, Cellular Physiology and Biochemistry.

[33]  P. Palatini,et al.  Glomerular hyperfiltration predicts the development of microalbuminuria in stage 1 hypertension: the HARVEST. , 2006, Kidney international.

[34]  S. Nielsen,et al.  Systolic Blood Pressure Relates to the Rate of Decline of Glomerular Filtration Rate in Type II Diabetes , 1993, Diabetes Care.

[35]  M. Burnier,et al.  Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  A. Fabris,et al.  Clinical features of patients with solitary kidneys. , 1986, Nephron.

[37]  B. Brenner,et al.  The hyperfiltration theory: a paradigm shift in nephrology. , 1996, Kidney international.

[38]  B. Brenner,et al.  Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[39]  J. Scholey,et al.  Renal Hyperfiltration and Arterial Stiffness in Humans With Uncomplicated Type 1 Diabetes , 2010, Diabetes Care.

[40]  B. Brenner,et al.  Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. , 1986, The Journal of clinical investigation.

[41]  G. Eknoyan,et al.  National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification , 2003, Annals of Internal Medicine.

[42]  G. Remuzzi,et al.  ACE inhibition is renoprotective among obese patients with proteinuria. , 2011, Journal of the American Society of Nephrology : JASN.

[43]  G. Dahlquist,et al.  RENAL FUNCTION IN RELATION TO METABOLIC CONTROL IN CHILDREN WITH DIABETES OF DIFFERENT DURATION , 1983, Acta paediatrica Scandinavica.

[44]  L. Solomon,et al.  Progressive renal failure in a remnant kidney. , 1985, British medical journal.

[45]  S. Nielsen,et al.  The clinical course of renal function in NIDDM patients with normo‐ and microalbuminuria , 1997, Journal of internal medicine.

[46]  I. Njølstad,et al.  Impaired Fasting Glucose Is Associated With Renal Hyperfiltration in the General Population , 2011, Diabetes Care.

[47]  F C Luft,et al.  Glomerular hyperfiltration during sympathetic nervous system activation in early essential hypertension. , 1997, Journal of the American Society of Nephrology : JASN.

[48]  M. Hargreaves,et al.  Glomerular hyperfiltration in insulin-dependent diabetes mellitus: no evidence for enhanced activity of the renin-angiotensin-aldosterone system. , 1991, The Journal of diabetic complications.

[49]  N. Kurtzman,et al.  Chapter III Role of Hyperfiltration in the Pathogenesis of Diabetic Nephropathy , 2011 .

[50]  U. Gafter,et al.  Obesity-induced glomerular hyperfiltration: its involvement in the pathogenesis of tubular sodium reabsorption. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[51]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[52]  R. Bilous,et al.  Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis , 2009, Diabetologia.

[53]  John E Hall,et al.  The kidney, hypertension, and obesity. , 2003, Hypertension.

[54]  D. Dunger,et al.  The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: The Oxford Regional Prospective Study. , 2005, Kidney international.

[55]  Da‐hong Wang,et al.  C-reactive protein is associated with cigarette smoking-induced hyperfiltration and proteinuria in an apparently healthy population , 2010, Hypertension Research.

[56]  E. Sochett,et al.  Evolution of Renal Hyperfiltration and Arterial Stiffness From Adolescence Into Early Adulthood in Type 1 Diabetes , 2011, Diabetes Care.

[57]  G. Remuzzi,et al.  Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition. , 2011, Journal of the American Society of Nephrology : JASN.

[58]  P. Palatini,et al.  Cystatin C as Predictor of Microalbuminuria in the Early Stage of Hypertension , 2009, Nephron Clinical Practice.